MC10 Collaborates with AbbVie for Multiple Sclerosis Clinical Trials Using BioStamp nPoint system

MC10 Collaborates with AbbVie for Multiple Sclerosis Clinical Trials Using BioStamp nPoint system

Image: Freepik

MC10, a Massachusetts-based startup specializing in wearable digital health sensors, and AbbVie, a global biopharmaceutical company, are working together on clinical trials in patients with multiple sclerosis (MS) using the BioStamp nPoint system.

Related Shimmer Launches Verisense™ Wearable Sensor Platform for Clinical Trials

The new partnership aims to explore the use of data from the nPoint® System in order to provide unique insights into MS clinical studies.

“We are excited to work with a world leader in CNS therapies and look forward to exploring novel data and metrics that help to advance clinical development,” said Dr Arthur Combs, Chief Medical Officer of MC10.

BioStamp nPoint System, which received 510(k) from the FDA, was developed for use in clinical trials and other applications for the continuous collection of physiological data. The system is optimized for both in-home and in-clinic use. The BioStamp nPoint System reports vital signs, activity and postural classifications and a suite of sleep metrics. Today, numerous pharmaceutical companies and academic research across several therapeutic areas use this system, said MC10 in a press release.

Dr. Michael Gold, Vice President, Development Neurosciences, of AbbVie said:

“We are excited to explore the BioStamp nPoint System’s ability to unobtrusively collect clinically relevant data continuously from subjects in more natural settings. This technology has the potential to improve the quality of data we collect and at the same time reduce the burden on study participants.”

Related Oracle mHealth Platform is Revolutionizing Clinical Trials with Remote Monitoring Devices

Based in Lexington, Massachusetts, MC10 combines its proprietary ultra-thin, flexible body-worn sensors with advanced analytics to unlock health insights from physiological data.

Lake Bluff, Illinois-based AbbVie was founded in 2013 as a spin-off of Abbott Laboratories.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Sam Draper
May 17, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Flexible Color E Ink Displays for Wearables Could Soon Become a Reality

Flexible displays have been discussed for years, but product designers couldn’t bring them to the...

Audibel Launches AI-Enabled Hearing Aids

Health Tech Firm Audibel announced the launch of its new artificial intelligence hearing aids...

eMacula Eyewear System Relieves Eyes of Having to Focus Too Hardly

Innovega has created a generation of eyewear that combines smart contact lenses and stylish glasses.

From Pregnant Mothers To Pets, Japan Is Making Swift Progress In The Race For Smart Clothes

Electronic textiles, or Smart textiles are fabrics that enable digital components..
Discover more